These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21393873)

  • 1. Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma.
    Jung EJ; Lee JH; Min BW; Kim YS; Choi JS
    Indian J Pathol Microbiol; 2011; 54(1):32-6. PubMed ID: 21393873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people.
    Tsai WC; Chao YC; Sheu LF; Lin YF; Nieh S; Chen A; Yu CP; Jin JS
    APMIS; 2007 Aug; 115(8):929-38. PubMed ID: 17696949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
    Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
    J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
    Stenzinger A; Wittschieber D; von Winterfeld M; Goeppert B; Kamphues C; Weichert W; Dietel M; Rabien A; Klauschen F
    Hum Pathol; 2012 Sep; 43(9):1471-81. PubMed ID: 22417846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
    Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
    J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
    Huang ZQ; Chen WL; Li HG; Li JS; Xu ZY; Lin ZY
    J Craniofac Surg; 2010 Nov; 21(6):1855-60. PubMed ID: 21119439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
    Dong W; Xiang J; Li C; Cao Z; Huang Z
    J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
    Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
    Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma.
    Abdou AG; Sakr S; Elwahed MM; Eladly EK
    Ultrastruct Pathol; 2016; 40(4):181-8. PubMed ID: 27042764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
    Won KY; Kim GY; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma.
    Cui Y; Li T; Zhang D; Han J
    Cancer Invest; 2010 Mar; 28(3):242-7. PubMed ID: 20158339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
    Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts.
    Ali MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):258-63. PubMed ID: 18554952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
    Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
    Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Zou J; Yang H; Chen F; Zhao H; Lin P; Zhang J; Ye H; Wang L; Liu S
    Eur J Cancer Prev; 2010 Jan; 19(1):11-7. PubMed ID: 19741544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.